我们可以治愈类风湿性关节炎吗?
Yi Yin1, Meiyu Guo1, Peter E Lipsky2
1Department of Rheumatology, Beijing Hospital, National Center of Gerontology, Clinical Immunology Center, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.
Current opinion in immunology
|May 13, 2025
概括
实现持续的无药缓解或治疗类风湿性关节炎 (RA) 仍然具有挑战性. 新兴的免疫疗法显示出对重新编程免疫反应的承诺,可能将重点从症状管理转移到疾病根除.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 治疗方法开发 治疗方法开发
背景情况:
- 风湿性关节炎 (RA) 是一种进展性的自身免疫性疾病,尽管目前的治疗方法.
- 很少实现持续无药缓解 (SDFR) 或治愈RA.
- 治愈的障碍包括免疫弹性,树皮激活,结构损伤和遗传学.
研究的目的:
- 审查RA治疗方面的进展.
- 评估新兴疗法是否可以导致免疫正常化和治愈.
- 评估新治疗方法的潜力,以从管理转向治愈.
主要方法:
- 关于RA治疗的当前文献的综述.
- 分析新兴疗法,如新生物药,细胞干预和基因编辑.
- 对疾病轨迹改变的临床前和早期临床数据的评估.
主要成果:
- 目前的治疗方法可以改善结果,但不能提供治愈.
- 新兴疗法旨在重编程免疫反应,为SDFR和治愈提供潜力.
- 早期数据表明疾病轨迹可能发生变化,但尚未证明持久的免疫重置.
结论:
- 对于RA来说,终极治愈尚未实现,但这是一个未来的目标.
- 精准医学,下一代免疫疗法和翻译性研究正在推动向治愈策略的转变.
- 早期干预的"机会窗口"仍然是RA治疗研究的关键领域.
相关概念视频
Genome-wide Association Studies-GWAS
12.2K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
12.2K
The JAK-STAT Signaling Pathway
8.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.6K
Connective Tissue Cell Types
3.1K
Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
3.1K
Autoimmune Disorders
363
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
363
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
106
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
106
T Cell Types and Functions
724
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
724


